Preparation and Evaluation of New [~(99)Tc~m(CO)_3]~+-Labelled Phenanthroline Complexes

YANG Yang,HAN Mei-jiao,WANG Ke-zhi,ZHU Lin
2009-01-01
Abstract:The chief requirement to determine if pharmaceuticals may be AD-tracer is that complexes can pass through BBB to enter the brain and have rapid clean from the brain.To develop early diagnose radiopharmaceuticals for Alzheimer's disease,new phenanthroline complexes 2-(9-anthryl)-1H-imidazo[4,5-f][1,10]phenanthroline(aip) and 2-(9-anthryl)-1ethyl-imidazo[4,5-f][1,10]phenanthroline(aeip) based on the early research of Ru complexes banding to DNA used for fluescence method were synthesized and labelled by 99Tcm-tricarbonyl core.Radiochemical purities of complexes 99Tcm(CO)+3-aip and 99Tcm(CO)+3-aeip were found to be more than 95% as proved by radio-HPLC.Paper electrophoresis show that these complexes are neutral.Biodistribution of these complexes in mice shows the higher early uptakes in brain(2 min,99Tcm(CO)+3-aip:(1.028±0.096)%ID/g;99Tcm(CO)+3-aeip:(1.191±0.197)%ID/g).
What problem does this paper attempt to address?